Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Glenmark Pharmaceuticals (GNP IN)
Watchlist
138
Analysis
Health Care
•
India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
361 Degrees International
•
04 Nov 2019 15:51
Asia HY Monthly - Corporate Governance And Corruption In Indonesia - Lucror Analytics
In this month’s “In-Focus” section, we provide an update on recent events in Indonesia that we believe will have an impact on offshore investor...
Lucror Analytics
Follow
411 Views
Share
bullish
•
361 Degrees International
•
24 Oct 2019 16:00
Asia HY Trade Recommendations - October 2019 - Lucror Analytics
The Asia HY Trade Recommendations report for October includes a summary of our recommendations, as well as our high-conviction ideas. We also...
Lucror Analytics
Follow
352 Views
Share
bullish
•
Glenmark Pharmaceuticals
•
08 Oct 2019 00:00
Lucror Analytics - Morning Views Asia - 08 Oct 2019
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...
Lucror Analytics
Follow
59 Views
Share
bullish
•
361 Degrees International
•
02 Oct 2019 00:00
Asia HY Monthly - Macau Gaming Update - Lucror Analytics
In this month’s In-Focus, we provide an update on the Macau gaming sector, including our market outlook, concession renewals and a peer...
Lucror Analytics
Follow
72 Views
Share
bullish
•
Glenmark Pharmaceuticals
•
27 Sep 2019 00:00
Glenmark - Tear Sheet - Lucror Analytics
We view Glenmark Pharmaceuticals as “Medium Risk” on the LARA scale. Our opinion is primarily based on the company’s sound track record of...
Lucror Analytics
Follow
49 Views
Share
First
Previous
17
18
19
20
21
22
23
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.36.0
x